Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor ? blockade in spondylarthropathy-Reference-Cited by-同舟云学术

Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor ? blockade in spondylarthropathy

Published:2004 Issue:9 Volume:50 Page:2942-2953
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Vandooren Bernard,Kruithof Elli,Yu David T. Y.,Rihl Markus,Gu Jieruo,De Rycke Leen,Van Den Bosch Filip,Veys Eric M.,De Keyser Filip,Baeten Dominique

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference52 articles.

1. Cytokine networks. In: Rheumatoid arthritis: new frontiers in pathogenesis and treatment. editors. New York: Oxford University Press; 2000. p. 147-63.

2. Bone destruction in arthritis

3. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases

4. In Situ Hybridization Studies of Stromelysin and Collagenase Messenger RNA Expression in Rheumatoid Synovium

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix Metalloproteinases; A Biomarker of Disease Activity and Prognosis in Spondyloarthritis: A Narrative Review;Current Reviews in Clinical and Experimental Pharmacology;2023-03

2. A2A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patients;BMC Musculoskeletal Disorders;2022-10-12

3. Extracellular matrix protein turnover markers are associated with axial spondyloarthritis—a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain;Arthritis Research & Therapy;2022-06-23

4. Downregulation of Tumour Necrosis Factor α Gene Expression in Peripheral Blood Mononuclear Cells Cultured in the Presence of Tofacitinib Prior to Therapy Is Associated with Clinical Remission in Patients with Rheumatoid Arthritis;Current Issues in Molecular Biology;2022-04-29

5. IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt;Frontiers in Immunology;2021-03-04